All Stories

  1. The X-ray crystal structure of the N-terminal domain of Ssr4, a Schizosaccharomyces pombe chromatin-remodelling protein
  2. Crystal structures of human ENPP1 in apo and bound forms
  3. Fragment screening for a protein-protein interaction inhibitor to WDR5
  4. The evolving story of AtzT, a periplasmic binding protein
  5. Structures of the transcriptional regulator BgaR, a lactose sensor
  6. Crystal structure of a putrescine aminotransferase fromPseudomonassp. strain AAC
  7. The structure of vanin 1: a key enzyme linking metabolic disease and inflammation
  8. Unprecedented conformational flexibility revealed in the ligand-binding domains of theBovicola ovisecdysone receptor (EcR) and ultraspiracle (USP) subunits
  9. 300-Fold Increase in Production of the Zn2+-Dependent Dechlorinase TrzN in Soluble Form via Apoenzyme Stabilization
  10. Cyclic Secondary Sulfonamides: Unusually Good Inhibitors of Cancer-Related Carbonic Anhydrase Enzymes
  11. Crystallization and preliminary X-ray diffraction analysis of the amidase domain of allophanate hydrolase fromPseudomonassp. strain ADP
  12. Interrogating HIV integrase for compounds that bind- a SAMPL challenge
  13. Nitrate in the active site of protein tyrosine phosphatase 1B is a putative mimetic of the transition state
  14. Crystallization reports are the backbone ofActa Cryst. F, but do they have any spine?
  15. Determination of the Structure of the Catabolic N-Succinylornithine Transaminase (AstC) from Escherichia coli
  16. Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?
  17. Fragment Screening for the Modelling Community: SPR, ITC, and Crystallography
  18. Crystal Structure of an Indole-3-Acetic Acid Amido Synthetase from Grapevine Involved in Auxin Homeostasis
  19. On the need for an international effort to capture, share and use crystallization screening data
  20. Structure of S. aureus HPPK and the Discovery of a New Substrate Site Inhibitor
  21. Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site
  22. The DINGO dataset: a comprehensive set of data for the SAMPL challenge
  23. Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design
  24. Identification and characterization of two families of F420H2‐dependent reductases from Mycobacteria that catalyse aflatoxin degradation
  25. A Human Monoclonal Antibody against Insulin-Like Growth Factor-II Blocks the Growth of Human Hepatocellular Carcinoma Cell Lines In vitro and In vivo
  26. The C6 Web Tool: A Resource for the Rational Selection of Crystallization Conditions
  27. Practical Aspects of the SAMPL Challenge: Providing an Extensive Experimental Data Set for the Modeling Community
  28. Crystallization and preliminary X-ray analysis of the complexes between a Fab and two forms of human insulin-like growth factor II
  29. Phoenito experiments: combining the strengths of commercial crystallization automation
  30. Tapping the Protein Data Bank for crystallization information